Cargando…

A deimmunized and pharmacologically optimized Toll-like receptor 5 agonist for therapeutic applications

The Toll-like receptor 5 (TLR5) agonist entolimod, a derivative of Salmonella flagellin, has therapeutic potential for several indications including radioprotection and cancer immunotherapy. However, in Phase 1 human studies, entolimod induced a rapid neutralizing immune response, presumably due to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mett, Vadim, Kurnasov, Oleg V., Bespalov, Ivan A., Molodtsov, Ivan, Brackett, Craig M., Burdelya, Lyudmila G., Purmal, Andrei A., Gleiberman, Anatoli S., Toshkov, Ilia A., Burkhart, Catherine A., Kogan, Yakov N., Andrianova, Ekaterina L., Gudkov, Andrei V., Osterman, Andrei L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8041767/ https://www.ncbi.nlm.nih.gov/pubmed/33846531 http://dx.doi.org/10.1038/s42003-021-01978-6

Ejemplares similares

Toll-like receptor-5 agonist Entolimod broadens the therapeutic window of 5-fluorouracil by reducing its toxicity to normal tissues in mice
por: Kojouharov, Bojidar M., et al.
Publicado: (2014)

The Toll-Like Receptor 5 Agonist Entolimod Mitigates Lethal Acute Radiation Syndrome in Non-Human Primates
por: Krivokrysenko, Vadim I., et al.
Publicado: (2015)

TLR5 agonist entolimod reduces the adverse toxicity of TNF while preserving its antitumor effects
por: Haderski, Gary J., et al.
Publicado: (2020)

Mobilan: a recombinant adenovirus carrying Toll-like receptor 5 self-activating cassette for cancer immunotherapy
por: Mett, V, et al.
Publicado: (2018)

Resistance of bone marrow stroma to genotoxic preconditioning is determined by p53
por: Fedtsova, Natalia, et al.
Publicado: (2021)

Superior cancer preventive efficacy of low versus high dose of mTOR inhibitor in a mouse model of prostate cancer
por: Antoch, Marina P., et al.
Publicado: (2020)

Signaling through TLR5 mitigates lethal radiation damage by neutrophil-dependent release of MMP-9
por: Brackett, Craig M., et al.
Publicado: (2021)

Cancer Relevance of Circulating Antibodies Against LINE-1 Antigens in Humans
por: Vylegzhanina, Alexandra V., et al.
Publicado: (2023)

Physiological frailty index (PFI): quantitative in-life estimate of individual biological age in mice
por: Antoch, Marina P., et al.
Publicado: (2017)

Inflammatory response to retrotransposons drives tumor drug resistance that can be prevented by reverse transcriptase inhibitors
por: Novototskaya-Vlasova, Ksenia A., et al.
Publicado: (2022)

A Flagellin-Derived Toll-Like Receptor 5 Agonist Stimulates Cytotoxic Lymphocyte-Mediated Tumor Immunity
por: Leigh, Nicholas D., et al.
Publicado: (2014)

The Toll-like receptor 5 agonist entolimod suppresses hepatic metastases in a murine model of ocular melanoma via an NK cell-dependent mechanism
por: Yang, Hua, et al.
Publicado: (2015)

New p35 (H3L) Epitope Involved in Vaccinia Virus Neutralization and Its Deimmunization
por: Khlusevich, Yana, et al.
Publicado: (2022)

Optimization algorithms for functional deimmunization of therapeutic proteins
por: Parker, Andrew S, et al.
Publicado: (2010)

Design and Engineering of Deimmunized Vaccinia Viral Vectors
por: Song, Kevin, et al.
Publicado: (2020)

Mutagenic Deimmunization of Diphtheria Toxin for Use in Biologic Drug Development
por: Schmohl, Joerg U., et al.
Publicado: (2015)

New nanoformulation of rapamycin Rapatar extends lifespan in homozygous p53(−/−) mice by delaying carcinogenesis
por: Comas, Maria, et al.
Publicado: (2012)

Deimmunization of flagellin for repeated administration as a vaccine adjuvant
por: Khim, Koemchhoy, et al.
Publicado: (2021)

Deimmunization of protein therapeutics – Recent advances in experimental and computational epitope prediction and deletion
por: Zinsli, Léa V., et al.
Publicado: (2020)

Mapping the Pareto Optimal Design Space for a Functionally Deimmunized Biotherapeutic Candidate
por: Salvat, Regina S., et al.
Publicado: (2015)

Immune checkpoint protein VSIG4 as a biomarker of aging in murine adipose tissue
por: Hall, Brandon M., et al.
Publicado: (2020)

Development of a Deimmunized Bispecific Immunotoxin dDT2219 against B-Cell Malignancies
por: Schmohl, Joerg U., et al.
Publicado: (2018)

Unsupervised learning of aging principles from longitudinal data
por: Avchaciov, Konstantin, et al.
Publicado: (2022)

First-in-human study of anticancer immunotherapy drug candidate mobilan: safety, pharmacokinetics and pharmacodynamics in prostate cancer patients
por: Eremina, Natalia V., et al.
Publicado: (2020)

Globally deimmunized lysostaphin evades human immune surveillance and enables highly efficacious repeat dosing
por: Zhao, Hongliang, et al.
Publicado: (2020)

ATM is activated in blood monocytes after tumor radiation
por: Gudkov, Andrei V., et al.
Publicado: (2013)

Experimental evolution in morbidostat reveals converging genomic trajectories on the path to triclosan resistance
por: Leyn, Semen A., et al.
Publicado: (2021)

Assessment of Sex, Age, and Metabolism Relationships to Serum Thyroid Concentrations in Retired Alaskan Husky Sled Dogs
por: Lenfest, Margret, et al.
Publicado: (2022)

AGING TREATMENT BY COUNTERACTING INTRINSIC DNA DAMAGE AND IMMUNOSENESCENCE
por: Gudkov, Andrei
Publicado: (2019)

Aging of mice is associated with p16(Ink4a)- and β-galactosidase-positive macrophage accumulation that can be induced in young mice by senescent cells
por: Hall, Brandon M., et al.
Publicado: (2016)

Crystal structure of 4-[(3-methylbut-3-enoyl)oxy]phenyl 4-n-hexyloxybenzoate
por: Kuz’mina, Lyudmila G., et al.
Publicado: (2017)

Selenium is a modulator of circadian clock that protects mice from the toxicity of a chemotherapeutic drug via upregulation of the core clock protein, BMAL1
por: Hu, Yan, et al.
Publicado: (2011)

Discovery of a Carbazole-Derived Lead Drug for Human African Trypanosomiasis
por: Thomas, Sarah M., et al.
Publicado: (2016)

Erratum: Discovery of a Carbazole-Derived Lead Drug for Human African Trypanosomiasis
por: Thomas, Sarah M., et al.
Publicado: (2017)

Development of infrastructure for a systemic multidisciplinary approach to study aging in retired sled dogs
por: Fleyshman, Daria I., et al.
Publicado: (2021)

Pretreatment of the Cells With Brefeldin A and Cycloheximide Differently Regulates Fas and TNF Stimulated Apoptosis
por: Neznanov, Nickolay, et al.
Publicado: (2001)

Proteotoxic stress targeted therapy (PSTT): induction of protein misfolding enhances the antitumor effect of the proteasome inhibitor bortezomib
por: Neznanov, Nickolay, et al.
Publicado: (2011)

Targeted Radionuclide Therapy of Human Tumors
por: Gudkov, Sergey V., et al.
Publicado: (2015)

Addressing the Immunogenicity of the Cargo and of the Targeting Antibodies with a Focus on Deimmunized Bacterial Toxins and on Antibody-Targeted Human Effector Proteins
por: Grinberg, Yehudit, et al.
Publicado: (2017)

Development of a novel fully functional coagulation factor VIII with reduced immunogenicity utilizing an in silico prediction and deimmunization approach
por: Winterling, Karina, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_36vmnda2iea9jhnqv386mvaa52